Cohance Lifesciences Limited

BSE:543064 Stock Report

Market Cap: ₹275.4b

Cohance Lifesciences Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Sudhir Singh

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.7yrs
CEO ownershipn/a
Management average tenure1.3yrs
Board average tenure1.6yrs

Recent management updates

Recent updates

CEO

Sudhir Singh (59 yo)

1.7yrs

Tenure

Dr. Sudhir Kumar Singh, Ph.D. serves as Chief Executive Officer since September 29, 2023 at Cohance Lifesciences Limited (formerly known as Suven Pharmaceuticals Limited) He served as Chief Operating Offic...

Leadership Team

NamePositionTenureCompensationOwnership
Vivek Sharma
Executive Chairmanless than a yearno datano data
Sudhir Singh
Chief Executive Officer1.7yrsno datano data
Himanshu Agarwal
Chief Financial Officer1.3yrsno datano data
Cyndrella Carvalho
Head of Investor Relationsno datano datano data
Kundan Jha
Company Secretary & Compliance Officerless than a yearno datano data
Gaurav Bahadur
Chief Human Resources Officer1.7yrsno datano data
Vetukuri Venkata Naga Kali Vara Raju
MD & Directorno datano datano data
Declan Ryan
Chief Commercial Officer1.3yrsno datano data
Sunder Venkatraman
Vice President of Corporate Affairs4.3yrsno datano data

1.3yrs

Average Tenure

54yo

Average Age

Experienced Management: 543064's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Vivek Sharma
Executive Chairmanless than a yearno datano data
Vetukuri Venkata Naga Kali Vara Raju
MD & Director1.7yrsno datano data
Abhijit Mukherjee
Member of Advisory Council1.6yrsno datano data
Venkateswarlu Jasti
Member of Advisory Council1.3yrs₹68.35mno data
Shweta Jalan
Non-Executive Director1.5yrsno datano data
Pankaj Patwari
Non-Executive Director1.7yrsno datano data
Vinod Rao
Independent Director1.7yrs₹1.36mno data
Matangi Gowrishankar
Independent Director1.7yrs₹1.36mno data
Stefan Stoffel
Member of Advisory Council1.6yrsno datano data
Pravin Udhyavara Rao
Independent Director1.5yrs₹1.07mno data
Annaswamy Vaidheesh
Vice-Chairperson of Advisory Councilless than a year₹27.27mno data
Kumarapuram Ananthakrishnan
Independent Director1.7yrs₹1.36m0.000050%
₹ 137.7k

1.6yrs

Average Tenure

63yo

Average Age

Experienced Board: 543064's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/13 01:54
End of Day Share Price 2025/05/13 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cohance Lifesciences Limited is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vijayaraghavan SwaminathanAvendus Spark
Harith AhamedAvendus Spark
Rohit BhatBatlivala & Karani Securities India Pvt. Ltd.